Patent | Date |
---|
Use of inactivated nonreplicating modified vaccinia virus Ankara (MVA) as monoimmunotherapy or in combination with immune checkpoint blocking agents for solid tumors Grant 11,426,460 - Deng , et al. August 30, 2 | 2022-08-30 |
Use Of Mva Or Mvadeltae3l As Immunotherapeutic Agents Against Solid Tumors App 20220211785 - DENG; Liang ;   et al. | 2022-07-07 |
Vaccinia Virus Mutants Useful For Cancer Immunotherapy App 20220186192 - Deng; Liang ;   et al. | 2022-06-16 |
Recombinant MVA or MVA.DELTA.E3L expressing human FLT3L and use thereof as immuno-therapeutic agents against solid tumors Grant 11,285,209 - Deng , et al. March 29, 2 | 2022-03-29 |
Recombinant Poxviruses For Cancer Immunotherapy App 20220056475 - DENG; Liang ;   et al. | 2022-02-24 |
Use of MVA or MVA.DELTA.E3L as immunotherapeutic agents against solid tumors Grant 11,253,560 - Deng , et al. February 22, 2 | 2022-02-22 |
Vaccinia virus mutants useful for cancer immunotherapy Grant 11,242,509 - Deng , et al. February 8, 2 | 2022-02-08 |
Heat-inactivated Vaccinia Virus As A Vaccine Immune Adjuvant App 20210177964 - DENG; Liang ;   et al. | 2021-06-17 |
Oncolytic Vaccinia Virus Expressing Immune Checkpoint Blockade For Cancer Immunotherapy App 20210023151 - DENG; Liang ;   et al. | 2021-01-28 |
Vaccinia Virus Mutants Useful For Cancer Immunotherapy App 20200339959 - Deng; Liang ;   et al. | 2020-10-29 |
Recombinant Mva Or Mvadele3l Expressing Human Flt3l And Use Thereof As Immuno-therapeutic Agents Against Solid Tumors App 20200316198 - DENG; Liang ;   et al. | 2020-10-08 |
Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human FLT3L or GM-CSF for cancer immunotherapy Grant 10,765,711 - Deng , et al. Sep | 2020-09-08 |
Recombinant MVA or MVADELE3L expressing human FLT3L and use thereof as immuno-therapeutic agents against solid tumors Grant 10,736,962 - Deng , et al. A | 2020-08-11 |
Use Of Inactivated Nonreplicating Modified Vaccinia Virus Ankara (mva) As Monoimmunotherapy Or In Combination With Immume Checkp App 20200237902 - Deng; Liang ;   et al. | 2020-07-30 |
Replication Competent Attenuated Vaccinia Viruses With Deletion Of Thymidine Kinase With And Without The Expression Of Human Flt App 20200237839 - DENG; Liang ;   et al. | 2020-07-30 |
Use Of Mva Or Mvadeltae3l As Immunotherapeutic Agents Against Solid Tumors App 20200222479 - DENG; Liang ;   et al. | 2020-07-16 |
Use of inactivated nonreplicating modified vaccinia virus Ankara (MVA) as monoimmunotherapy or in combination with immune checkpoint blocking agents for solid tumors Grant 10,639,366 - Deng , et al. | 2020-05-05 |
Use of MVA or MVA.DELTA.E3L as immunotherapeutic agents against solid tumors Grant 10,548,930 - Deng , et al. Fe | 2020-02-04 |
Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human Flt3L or GM-CSF for cancer immunotherapy Grant 10,512,662 - Deng , et al. Dec | 2019-12-24 |
Replication Competent Attenuated Vaccinia Viruses With Deletion Of Thymidine Kinase With And Without The Expression Of Human Flt3l Or Gm-csf For Cancer Immunotherapy App 20190054131 - DENG; Liang ;   et al. | 2019-02-21 |
Recombinant Mva Or Mvadele3l Expressing Human Flt3l And Use Thereof As Immuno-therapeutic Agents Against Solid Tumors App 20190046640 - DENG; Liang ;   et al. | 2019-02-14 |
Use Of Inactivated Nonreplicating Modified Vaccinia Virus Ankara (mva) As Monoimmunotherapy Or In Combination With Immume Checkpoint Blocking Agents For Solid Tumors App 20180236062 - Deng; Liang ;   et al. | 2018-08-23 |
Use Of Mva Or Mvadeltae3l As Immunotherapeutic Agents Against Solid Tumors App 20180078591 - DENG; Liang ;   et al. | 2018-03-22 |
Methods And Reagents For Molecular Cloning App 20150093788 - CHESNUT; Jonathan ;   et al. | 2015-04-02 |
Method for molecular cloning and polynucleotide synthesis using vaccinia DNA topoisomerase Grant 8,551,739 - Shuman October 8, 2 | 2013-10-08 |
Covalent Joining of DNA Strands to RNA Strands Catalyzed by Vaccinia Topoisomerase App 20120322109 - SHUMAN; STEWART ;   et al. | 2012-12-20 |
Covalent joining of DNA strands to RNA strands catalyzed by vaccinia topoisomerase Grant 8,192,932 - Shuman , et al. June 5, 2 | 2012-06-05 |
Methods And Reagents For Molecular Cloning App 20120129225 - Chesnut; Jonathan D. ;   et al. | 2012-05-24 |
Covalent joining of DNA strands to RNA strands catalyzed by vaccinia topoisomerase App 20100317064 - Shuman; Stewart ;   et al. | 2010-12-16 |
Covalent joining of DNA to RNA by vaccinia topoisomerase and uses thereof Grant 7,662,556 - Shuman , et al. February 16, 2 | 2010-02-16 |
Methods And Reagents For Molecular Cloning App 20090328244 - Chesnut; Jonathan D. ;   et al. | 2009-12-31 |
Method for molecular cloning and polynucleotide synthesis using vaccinia DNA topoisomerase Grant 7,550,295 - Shuman June 23, 2 | 2009-06-23 |
Methods and reagents for molecular cloning Grant 7,528,241 - Chesnut , et al. May 5, 2 | 2009-05-05 |
Method for molecular cloning and polynucleotide synthesis using vaccinia DNA topoisomerase App 20090068708 - Shuman; Stewart | 2009-03-12 |
Method for molecular cloning and polynucleotide synthesis using vaccinia DNA topoisomerase App 20060160072 - Shuman; Stewart | 2006-07-20 |
Pharmacological targeting of bacterial DNA ligase for treatment and prevention of bacterial infections App 20060134642 - Shuman; Stewart ;   et al. | 2006-06-22 |
Topoisomerase-based reagents and methods for molecular cloning Grant 7,026,141 - Shuman April 11, 2 | 2006-04-11 |
Methods and reagents for molecular cloning App 20050282184 - Chesnut, Jonathan D. ;   et al. | 2005-12-22 |
Methods and reagents for molecular cloning Grant 6,916,632 - Chesnut , et al. July 12, 2 | 2005-07-12 |
Pharmacological targeting of mRNA cap formation for treatment of parasitic infections Grant 6,844,167 - Shuman , et al. January 18, 2 | 2005-01-18 |
Pharmacological targeting of bacterial DNA ligase for treatment and prevention of bacterial infections Grant 6,787,341 - Shuman , et al. September 7, 2 | 2004-09-07 |
Covalent joining of DNA to RNA by vaccinia topoisomerase and uses thereof App 20040058417 - Shuman, Stewart ;   et al. | 2004-03-25 |
Topoisomerase-based ligation and cloning methods Grant 6,653,106 - Shuman , et al. November 25, 2 | 2003-11-25 |
Topoisomerase-based reagents and methods for molecular cloning App 20030215925 - Shuman, Stewart | 2003-11-20 |
Pharmacological targeting of mRNA cap formation for treatment of parasitic infections App 20030166209 - Shuman, Stewart ;   et al. | 2003-09-04 |
Pharmacological targeting of bacterial DNA ligase for treatment and prevention of bacterial infections App 20030036647 - Shuman, Stewart ;   et al. | 2003-02-20 |
Methods and reagents for molecular cloning App 20030022179 - Chesnut, Jonathan D. ;   et al. | 2003-01-30 |
Pharmacological targeting of mRNA cap formation Grant 6,232,070 - Shuman May 15, 2 | 2001-05-15 |
Method for molecular cloning and polynucleotide synthesis using vaccinia DNA topoisomerase Grant 5,766,891 - Shuman June 16, 1 | 1998-06-16 |